Head_Type,Head_Entity,Relation,Tail_Type,Tail_Entity,Description
Biomarker,GM2 ganglioside,is_associated_with,Pathological_Change,Aβ aggregation,GM2神经节苷脂与Aβ聚集相关
<Risk_Factor,cardiovascular disease,increases_risk_of,Disease,Alzheimer's disease,心血管疾病与阿尔茨海默病风险增加相关>
Protein,tau,is_targeted_by,Treatment,methylene blue,亚甲蓝抑制tau聚集
Disease,Alzheimer's disease,has_symptom,Clinical_Manifestation,aphasia,阿尔茨海默病可能导致失语症
Disease,Alzheimer's disease,has_treatment,Treatment,gantenerumab,甘特鲁单抗是治疗阿尔茨海默病的单克隆抗体
Risk_Factor,head injuries,increases_risk_of,Disease,Alzheimer's disease,头部受伤增加阿尔茨海默病的风险
Imaging_Method,PET,detects,Biomarker,brain amyloid,正电子发射断层扫描用于检测脑淀粉样蛋白
Protein,α-synuclein,is_targeted_by,Treatment,posiphen,Posiphen减少α-突触核蛋白的产生
Disease,Alzheimer's disease,has_treatment,Treatment,saracatinib,Saracatinib通过抑制蛋白激酶减少tau水平及其磷酸化形式
Gene,PSEN1,increases_risk_of,Disease,Alzheimer's disease,PSEN1基因增加阿尔茨海默病的风险
Protein,APP,is_targeted_by,Treatment,α-secretase modulators,α-分泌酶调节剂刺激APP的切割
Disease,Alzheimer's disease,affects,Brain_Region,amygdala,阿尔茨海默病影响杏仁核
Protein,β-amyloid,is_targeted_by,Treatment,gantenerumab,甘特鲁单抗靶向β-淀粉样蛋白并清除它
Protein,VPS35,is_targeted_by,Treatment,R55,R55作为小分子药理学伴侣靶向VPS35
Imaging_Method,MRI,detects,Pathological_Change,brain atrophy,核磁共振检测脑萎缩
Biomarker,cerebrospinal fluid tau,indicates,Pathological_Change,neuronal injury,脑脊液中的tau蛋白指示神经元损伤
Risk_Factor,infections,increases_risk_of,Disease,Alzheimer's disease,感染增加阿尔茨海默病的风险
Treatment,NMDA antagonists,treats,Disease,Alzheimer's disease,NMDA拮抗剂用于治疗阿尔茨海默病
Biomarker,Aβ,is_associated_with,Pathological_Change,amyloid plaques,Aβ是淀粉样斑块的生物标志物
Disease,Alzheimer's disease,has_treatment,Treatment,posiphen,Posiphen通过选择性抑制APP减少淀粉样蛋白、tau蛋白和α-突触核蛋白的产生
Protein,β-amyloid,is_targeted_by,Treatment,aducanumab,阿杜卡单抗靶向β-淀粉样蛋白并清除它
Disease,Alzheimer's disease,has_treatment,Treatment,PTI-125,PTI-125通过抑制Filamin A蛋白减少tau过度磷酸化
Disease,Alzheimer's disease,has_treatment,Treatment,tideglusib,Tideglusib通过抑制糖原合成酶激酶3减少tau过度磷酸化
<Treatment,galantamine,treats,Disease,Alzheimer's disease,加兰他敏用于改善阿尔茨海默病的行为症状和认知功能>
Gene,APOE,increases_risk_of,Disease,Alzheimer's disease,APOE基因增加阿尔茨海默病的风险
Disease,Alzheimer's disease,has_treatment,Treatment,TRx0237,TRx0237是抑制tau蛋白聚集的药物
Biomarker,fluorodeoxyglucose,indicates,Pathological_Change,metabolic activity,氟脱氧葡萄糖指示代谢活动
Disease,Alzheimer's disease,has_treatment,Treatment,Natural Extract,天然提取物通过多种机制途径显示出治疗阿尔茨海默病的潜力
Clinical_Stage,moderate stage,precedes,Clinical_Stage,severe stage,阿尔茨海默病的中度阶段先于重度阶段
Protein,Hsp70,is_targeted_by,Treatment,YM-01,YM-01抑制Hsp70的ATP结合位点
Protein,APP,is_targeted_by,Treatment,posiphen,Posiphen选择性抑制APP
Protein,amyloid-beta,accumulates_in,Brain_Region,brain,淀粉样蛋白在大脑中异常堆积
Gene,PSEN2,increases_risk_of,Disease,Alzheimer's disease,PSEN2基因增加阿尔茨海默病的风险
<Risk_Factor,diet,increases_risk_of,Disease,Alzheimer's disease,饮食因素与阿尔茨海默病风险增加相关>
Protein,α-secretase,is_targeted_by,Treatment,bryostatin,Bryostatin诱导α-分泌酶活性
Gene,APP,increases_risk_of,Disease,Alzheimer's disease,APP基因增加阿尔茨海默病的风险
Disease,Alzheimer's disease,has_treatment,Treatment,PQ912,PQ912通过抑制谷氨酰环化酶减少淀粉样斑块和焦谷氨酸Aβ的产生
Disease,Alzheimer's disease,has_symptom,Clinical_Manifestation,memory loss,阿尔茨海默病的主要症状是记忆力丧失
Risk_Factor,vascular diseases,increases_risk_of,Disease,Alzheimer's disease,血管疾病增加阿尔茨海默病的风险
<Gene,VDR,is_associated_with,Disease,Alzheimer's disease,维生素D受体基因多态性与阿尔茨海默病风险增加相关>
Clinical_Test,MMSE,evaluates,Clinical_Manifestation,cognitive function,简易精神状态检查评估认知功能
Biomarker,GM3 ganglioside,is_associated_with,Pathological_Change,Aβ aggregation,GM3神经节苷脂与Aβ聚集相关
<Gene,ESR,is_associated_with,Disease,Alzheimer's disease,雌激素受体基因与阿尔茨海默病风险相关>
Disease,Alzheimer's disease,has_treatment,Treatment,Hsp60,Hsp60通过抑制活化的小胶质细胞和Hsp60表达预防神经退行性疾病
Research_Method,knockout studies,investigates,Gene,PSEN1,敲除研究用于研究PSEN1基因
Protein,CD38,is_targeted_by,Treatment,daratumumab,达雷木单抗靶向CD38调节小胶质细胞活性
Protein,tau,forms,Pathological_Change,neurofibrillary tangles,tau蛋白形成神经纤维缠结
Risk_Factor,aging,increases_risk_of,Disease,Alzheimer's disease,年龄增长是阿尔茨海默病的风险因素
Disease,Alzheimer's disease,has_treatment,Treatment,Heat Shock Proteins,热休克蛋白通过协助蛋白质折叠改善蛋白质质量控制系统的效率
<Gene,ECSIT,is_associated_with,Disease,Alzheimer's disease,ECSIT基因与阿尔茨海默病风险增加相关>
Protein,tau,is_targeted_by,Treatment,OT1001,OT1001减少tau聚集
Protein,tau,is_targeted_by,Treatment,Hsp70,Hsp70结合tau并减少其聚集
<Gene,ABCA1,regulates,Protein,ApoE,ABCA1基因调节ApoE蛋白质的脂化稳定性>
<Risk_Factor,metals,increases_risk_of,Disease,Alzheimer's disease,金属暴露与阿尔茨海默病风险增加相关>
Protein,Hsp90,is_targeted_by,Treatment,radicicol,Radicicol抑制Hsp90
<Gene,CLU,is_associated_with,Disease,Alzheimer's disease,CLU基因是晚发性阿尔茨海默病的风险因素>
Gene,APOE4,increases_risk_of,Disease,Alzheimer's disease,APOE4基因增加阿尔茨海默病的风险
Biomarker,synaptotagmin-1,indicates,Pathological_Change,synaptic loss,突触结合蛋白-1指示突触损失
Clinical_Stage,pre-clinical stage,precedes,Clinical_Stage,mild stage,阿尔茨海默病的临床前阶段先于轻度阶段
Biomarker,visinin-like protein-1,indicates,Pathological_Change,synaptic loss,视黄醇样蛋白-1指示突触损失
Protein,β-hexosaminidase,is_targeted_by,Treatment,OT1001,OT1001增加β-己糖胺酶活性
Disease,Alzheimer's disease,has_treatment,Treatment,Hsp90,Hsp90通过调节tau磷酸化和去磷酸化减少tau病理
Protein,tau,is_targeted_by,Treatment,saracatinib,Saracatinib减少tau水平及其磷酸化形式
Protein,GSK3β,is_targeted_by,Treatment,tideglusib,Tideglusib抑制糖原合成酶激酶3
Biomarker,VPS35,is_associated_with,Pathological_Change,synaptic dysfunction,VPS35与突触功能障碍相关
Disease,Alzheimer's disease,has_treatment,Treatment,methylene blue,亚甲蓝通过抑制tau聚集减少阿尔茨海默病的进展
Disease,Alzheimer's disease,has_treatment,Treatment,riluzole,利鲁唑通过抑制tau聚集减少阿尔茨海默病的进展
Protein,ABCC1,is_targeted_by,Treatment,thiethylperazine,硫乙拉嗪激活ABCC1转运蛋白
Protein,Hsp90,is_targeted_by,Treatment,17-AAG,17-AAG抑制Hsp90
Clinical_Stage,mild stage,precedes,Clinical_Stage,moderate stage,阿尔茨海默病的轻度阶段先于中度阶段
Protein,tau,is_targeted_by,Treatment,TRx0237,TRx0237抑制tau蛋白聚集
<Treatment,memantine,treats,Disease,Alzheimer's disease,美金刚用于治疗中度至重度阿尔茨海默病>
Protein,tau,is_targeted_by,Treatment,VPS35,VPS35减少tau神经病理学
Disease,Alzheimer's disease,has_treatment,Treatment,lithium,锂通过调节神经递质受体离子通道改善神经精神症状
<Gene,BIN1,is_associated_with,Disease,Alzheimer's disease,BIN1基因是晚发性阿尔茨海默病的第二重要风险因素>
Disease,Alzheimer's disease,has_treatment,Treatment,nilotinib,尼洛替尼通过抑制酪氨酸激酶促进淀粉样蛋白和tau蛋白的清除
Disease,Alzheimer's disease,has_treatment,Treatment,bryostatin,Bryostatin通过诱导α-分泌酶活性减少Aβ产生并增强学习和记忆
Disease,Alzheimer's disease,affects,Brain_Region,hippocampus,阿尔茨海默病影响海马体
Clinical_Test,neuropsychological tests,evaluates,Clinical_Manifestation,cognitive function,神经心理学测试用于评估认知功能
Disease,Alzheimer's disease,has_treatment,Treatment,IONIS MAPTRx,IONIS MAPTRx是减少tau蛋白产生的反义寡核苷酸
Protein,Hsp70,is_targeted_by,Treatment,JG-98,JG-98抑制Hsp70的ATP结合位点
<Treatment,rivastigmine,treats,Disease,Alzheimer's disease,利斯的明用于治疗轻度至中度阿尔茨海默病>
Disease,Alzheimer's disease,has_symptom,Clinical_Manifestation,agnosia,阿尔茨海默病可能导致失认症
Disease,Alzheimer's disease,has_treatment,Treatment,OT1001,OT1001通过增加β-己糖胺酶活性减少GM2水平和Aβ聚集
Protein,tau,is_targeted_by,Treatment,riluzole,利鲁唑抑制tau聚集
<Risk_Factor,obesity,increases_risk_of,Disease,Alzheimer's disease,肥胖与阿尔茨海默病风险增加相关>
Disease,Alzheimer's disease,has_treatment,Treatment,VPS35,VPS35通过减少Aβ肽和tau神经病理学改善阿尔茨海默病的症状
Disease,Alzheimer's disease,has_treatment,Treatment,aducanumab,阿杜卡单抗是治疗阿尔茨海默病的单克隆抗体
Research_Method,knock-in studies,investigates,Gene,PSEN1,敲入研究用于研究PSEN1基因
Protein,Hsp60,is_targeted_by,Treatment,mizoribine,米唑立宾抑制Hsp60的ATP酶活性
Disease,Alzheimer's disease,causes,Pathological_Change,neuritic plaques,阿尔茨海默病导致神经炎性斑块的形成
Protein,tau,is_targeted_by,Treatment,tideglusib,Tideglusib抑制tau过度磷酸化
Biomarker,neurogranin,indicates,Pathological_Change,synaptic loss,神经颗粒蛋白指示突触损失
Risk_Factor,environmental factors,increases_risk_of,Disease,Alzheimer's disease,环境因素增加阿尔茨海默病的风险
Treatment,donepezil,treats,Disease,Alzheimer's disease,多奈哌齐用于治疗阿尔茨海默病
Disease,Alzheimer's disease,has_treatment,Treatment,BAN2401,BAN2401是减少原纤维β-淀粉样蛋白的单克隆抗体
Disease,Alzheimer's disease,has_treatment,Treatment,Hsp70,Hsp70通过结合Aβ42和tau减少其聚集并促进tau与微管的结合
<Treatment,DMT,modifies,Disease,Alzheimer's disease,疾病修饰治疗旨在改变阿尔茨海默病的进展>
Protein,GM3 ganglioside,is_targeted_by,Treatment,OT1001,OT1001减少GM3水平
Risk_Factor,genetic mutations,increases_risk_of,Disease,Alzheimer's disease,基因突变增加阿尔茨海默病的风险
Imaging_Method,MRI,detects,Biomarker,brain atrophy,核磁共振用于检测脑萎缩
Disease,Alzheimer's disease,causes,Pathological_Change,neurofibrillary tangles,阿尔茨海默病导致神经纤维缠结的形成
Protein,β-amyloid,is_targeted_by,Treatment,BAN2401,BAN2401减少原纤维β-淀粉样蛋白
Protein,α-secretase,is_targeted_by,Treatment,APH-1105,APH-1105调节α-分泌酶活性
<Risk_Factor,air pollution,increases_risk_of,Disease,Alzheimer's disease,空气污染与阿尔茨海默病风险增加相关>
Protein,tubulin,is_targeted_by,Treatment,TPI-287,TPI-287稳定微管结合并减少tau介导的细胞损伤
Disease,Alzheimer's disease,affects,Brain_Region,cerebral cortex,阿尔茨海默病影响大脑皮层
Disease,Alzheimer's disease,has_treatment,Treatment,CAD106b,CAD106b是刺激产生抗β-淀粉样蛋白抗体的疫苗
<Treatment,donepezil,treats,Disease,Alzheimer's disease,多奈哌齐用于治疗阿尔茨海默病症状>
<Risk_Factor,infections,increases_risk_of,Disease,Alzheimer's disease,慢性感染与阿尔茨海默病风险增加相关>
<Gene,ABCA1,increases_risk_of,Disease,Alzheimer's disease,ABCA1基因缺陷增加淀粉样斑块，与阿尔茨海默病相关>
Biomarker,tau,is_associated_with,Pathological_Change,neurofibrillary tangles,tau是神经纤维缠结的生物标志物
Protein,GM2 ganglioside,is_targeted_by,Treatment,OT1001,OT1001减少GM2水平
Protein,tau,is_targeted_by,Treatment,Hsp90,Hsp90调节tau磷酸化和去磷酸化
Clinical_Test,MRI,detects,Pathological_Change,brain atrophy,核磁共振可以检测到脑萎缩
Risk_Factor,aging,increases_risk_of,Disease,Alzheimer's disease,衰老增加阿尔茨海默病的风险
Protein,β-amyloid,is_targeted_by,Treatment,CAD106b,CAD106b刺激产生抗β-淀粉样蛋白的抗体
<Risk_Factor,diabetes,increases_risk_of,Disease,Alzheimer's disease,糖尿病与阿尔茨海默病风险增加相关>
Protein,tau,is_targeted_by,Treatment,IONIS MAPTRx,IONIS MAPTRx减少tau蛋白的产生
Disease,Alzheimer's disease,has_symptom,Clinical_Manifestation,apraxia,阿尔茨海默病可能导致失用症
